Advanced in Sturge-Weber Syndrome

Dr. Hakan Demirci

Ophthalmology
Regents Of The University Of Michigan
1000 Wall St, 
Ann Arbor, MI 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Advanced in Sturge-Weber Syndrome
Regents Of The University Of Michigan
1000 Wall St, 
Ann Arbor, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hakan Demirci is an Ophthalmologist in Ann Arbor, Michigan. Dr. Demirci and is rated as an Advanced provider by MediFind in the treatment of Sturge-Weber Syndrome. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Choroid Plexus Carcinoma, and Vitrectomy. Dr. Demirci is currently accepting new patients.

His clinical research consists of co-authoring 136 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Licenses
Ophthalmology in MI
Hospital Affiliations
University Of Michigan Health System
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
Priority Health
  • HMO
  • POS

Locations

REGENTS OF THE UNIVERSITY OF MICHIGAN
1000 Wall St, Ann Arbor, MI 48105

Additional Areas of Focus

Dr. Demirci has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Enrollment Status: Recruiting
Publish Date: December 21, 2023
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 2 Open-label, Ascending Single and Repeat Dose Escalation Trial of Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
A Phase 2 Open-label, Ascending Single and Repeat Dose Escalation Trial of Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Enrollment Status: Completed
Publish Date: March 03, 2025
Intervention Type: Device, Drug
Study Drug: AU-011
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
View 3 Less Clinical Trials

136 Total Publications

Clinical outcomes of 3-dimensional printed custom porous polyethylene orbital implant for reconstruction.
Clinical outcomes of 3-dimensional printed custom porous polyethylene orbital implant for reconstruction.
Journal: European journal of ophthalmology
Published: April 15, 2025
Similar Doctors
Experienced in Sturge-Weber Syndrome
Dr. Mark W. Johnson
Ophthalmology
Experienced in Sturge-Weber Syndrome
Dr. Mark W. Johnson
Ophthalmology

Regents Of The University Of Michigan

1000 Wall St, 
Ann Arbor, MI 
 (0.1 mi)
734-764-4190
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Johnson is an Ophthalmologist in Ann Arbor, Michigan. Dr. Johnson and is rated as an Advanced provider by MediFind in the treatment of Sturge-Weber Syndrome. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, and Neuroretinitis. Dr. Johnson is currently accepting new patients.

Experienced in Sturge-Weber Syndrome
Dr. David N. Zacks
Ophthalmology
Experienced in Sturge-Weber Syndrome
Dr. David N. Zacks
Ophthalmology

Regents Of The University Of Michigan

1000 Wall St, 
Ann Arbor, MI 
 (0.1 mi)
734-764-4190
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Zacks is an Ophthalmologist in Ann Arbor, Michigan. Dr. Zacks and is rated as an Elite provider by MediFind in the treatment of Sturge-Weber Syndrome. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Vitrectomy. Dr. Zacks is currently accepting new patients.

Experienced in Sturge-Weber Syndrome
Dr. Manjool M. Shah
Ophthalmology
Experienced in Sturge-Weber Syndrome
Dr. Manjool M. Shah
Ophthalmology

Regents Of The University Of Michigan

1000 Wall St, 
Ann Arbor, MI 
 (0.1 mi)
734-764-4190
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Manjool Shah is an Ophthalmologist in Ann Arbor, Michigan. Dr. Shah and is rated as a Distinguished provider by MediFind in the treatment of Sturge-Weber Syndrome. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal. Dr. Shah is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Demirci's expertise for a condition
ConditionClose
View All 23 Advanced Conditions
View All 39 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile